Significant Phase III Results With CIMZIA(TM) in Rheumatoid Arthritis - PR Newswire (press release)
February 23, 2007| Significant Phase III Results With CIMZIA(TM) in Rheumatoid Arthritis PR Newswire (press release), NY - 2 (3) Stakeholder Insight: Rheumatoid Arthritis, Biologics battle up the treatment algorithm, Data Monitor, 7 September 2006 (4) Woolf AD & Pfleger B, ... Significant Phase III Results With Cimzia in Rheumatoid Arthritis Significant Phase III Results With CIMZIA(TM) In Rheumatoid ... |
Bone's Proactive Arthritis Drug Attacks The Cause Of Arthritic Pain - Medical News Today (press release)
February 23, 2007| Bone's Proactive Arthritis Drug Attacks The Cause Of Arthritic Pain Medical News Today (press release), UK - "Bone's TNF down-regulator is a second-generation approach to the treatment of rheumatoid arthritis and has tremendous promise because of its potential to ... |
Brussels shares close lower on thin Friday trade, lower Wall ... - Forbes
February 23, 2007| Brussels shares close lower on thin Friday trade, lower Wall ... Forbes, NY - UCB said that Cimzia treatment for rheumatoid arthritis, in combination with methotrexate, prevented structural damage of the joints to a significantly ... |
Brussels shares lower midmorning in quiet trade - ABCmoney.co.uk
February 23, 2007| Brussels shares lower midmorning in quiet trade ABCmoney.co.uk, UK - UCB said that Cimzia treatment for rheumatoid arthritis, in combination with methotrexate, prevented structural damage of the joints to a significantly ... |
Significant Phase III Results With Cimzia in Rheumatoid Arthritis - PharmaLive.com (press release)
February 23, 2007| Significant Phase III Results With Cimzia in Rheumatoid Arthritis PharmaLive.com (press release), PA - ... of clinical trials are designed to establish the efficacy and tolerability of CIMZIA(TM) (certolizumab pegol) in the treatment of rheumatoid arthritis. ... Significant Phase III Results With CIMZIA(TM) in Rheumatoid Arthritis Significant Phase III Results With CIMZIA(TM) In Rheumatoid ... |
Significant Phase III Results with CIMZIA(TM) in Rheumatoid Arthritis - SYS-CON Media
February 23, 2007| Significant Phase III Results with CIMZIA(TM) in Rheumatoid Arthritis SYS-CON Media, NJ - ... on CIMZIA(TM) (certolizumab pegol), the first PEGylated, Fc-free anti-TNF, intended for the treatment of moderate to severe rheumatoid arthritis (RA). ... |
Significant Phase III Results with CIMZIA(TM) in Rheumatoid Arthritis - PipelineReview.com (press release)
February 23, 2007| Significant Phase III Results with CIMZIA(TM) in Rheumatoid Arthritis PipelineReview.com (press release), Spain - ... on CIMZIA(TM) (certolizumab pegol), the first PEGylated, Fc-free anti-TNF, intended for the treatment of moderate to severe rheumatoid arthritis (RA). ... |
UCB says Cimzia shows 'significant' results in preventing damage ... - Forbes
February 23, 2007| UCB says Cimzia shows 'significant' results in preventing damage ... Forbes, NY - BRUSSELS (AFX) - Pharmaceutical group UCB SA said its Cimzia treatment for rheumatoid arthritis, in combination with methotrexate, prevented structural ... |
Significant Phase III Results with CIMZIA(TM) in Rheumatoid Arthritis - Market Wire (press release)
February 23, 2007| Significant Phase III Results with CIMZIA(TM) in Rheumatoid Arthritis Market Wire (press release) - ... on CIMZIA™ (certolizumab pegol), the first PEGylated, Fc-free anti-TNF, intended for the treatment of moderate to severe rheumatoid arthritis (RA). ... |